Connable Office Inc Meridian Bioscience Inc Transaction History

Connable Office Inc

  • $920 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
BUY
$19.97 - $26.94 $251,282 - $338,986
12,583 New
12,583 $327,000
Q4 2021

Feb 14, 2022
SELL
$17.46 - $21.61 $200,720 - $248,428
-11,496 Closed
0 $0
Q2 2021

Aug 06, 2021
SELL
$18.01 - $28.32 $83,800 - $131,772
-4,653 Reduced 28.81%
11,496 $255,000
Q1 2021

May 07, 2021
BUY
$19.76 - $29.89 $319,104 - $482,693
16,149 New
16,149 $424,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Connable Office Inc Portfolio

Follow Connable Office Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connable Office Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email